Our Cooling to Help Injured Lungs (CHILL) trial of therapeutic hypothermia in ARDS includes neuromuscular blockade (NMB) as an inclusion criterion to avoid shivering. NMB has been used to facilitate mechanical ventilation in ARDS and was shown to reduce mortality in the ACURASYS trial. To assess the feasibility of a multi-center CHILL trial, we conducted a survey of academic intensivists about their NMB use in patients with ARDS.
METHODS:
We distributed via email a 16-question survey about NMB use in patients with ARDS including frequency, indications, and dosing strategy.
RESULTS:
212 (24.3%) of 871 respondents completed the survey: 94.7% were board-certified in internal medicine, 88% in pulmonary and critical care; 90.3% practiced in academic medical centers, with 87% working in medical ICUs; 96.6% of respondents who treat ARDS use NMB, and 39.7% use NMB in ≥ 50% of these patients. Of 4 listed indications for initiating NMB in ARDS, allowing adherence with lung-protective ventilator strategies and patient–ventilator synchrony were cited as the most important reasons, followed by the results of the ACURASYS trial and facilitating prone positioning.
CONCLUSIONS:
We conclude that NMB is frequently used by academic intensivists to facilitate mechanical ventilation in patients with moderate to severe ARDS.
LiG, MalinchocM, Cartin-CebaR, VenkataCV, KorDJ, PetersSG, et al. Eight-year trend of acute respiratory distress syndrome: a population-based study in Olmsted County, Minnesota. Am J Respir Crit Care Med, 2011; 183(1):59–66.
2.
RubenfeldGD, CaldwellE, PeabodyE, WeaverJ, MartinDP, NeffM, et al. Incidence and outcomes of acute lung injury. N Engl J Med, 2005; 353(16):1685–1693.
3.
HerridgeMS, CheungAM, TanseyCM, Matte-MartynA, Diaz-GranadosN, Al-SaidiF, et al. One-year outcomes in survivors of the acute respiratory distress syndrome. New Engl J Med, 2003; 348(8):683–693.
4.
HerridgeMS, TanseyCM, MatteA, TomlinsonG, Diaz-GranadosN, CooperA, et al. Functional disability 5 years after acute respiratory distress syndrome. New Engl J Med, 2011; 364(14):1293–1304.
5.
McHughLG, MilbergJA, WhitcombME, SchoeneRB, MaunderRJ, HudsonLD. Recovery of function in survivors of the acute respiratory distress syndrome. Am J Respir Crit Care Med, 1994; 150(1):90–94.
6.
FanE, DowdyDW, ColantuoniE, Mendez-TellezPA, SevranskyJE, ShanholtzC, et al. Physical complications in acute lung injury survivors: a two-year longitudinal prospective study. Crit Care Med, 2014; 42(4):849–859.
7.
NeedhamDM, WozniakAW, HoughCL, MorrisPE, DinglasVD, JacksonJC, et al. Risk factors for physical impairment after acute lung injury in a national, multicenter study. Am J Respir Crit Care Med, 2014; 189(10):1214–1224.
8.
BienvenuOJ, ColantuoniE, Mendez-TellezPA, DinglasVD, ShanholtzC, HusainN, et al. Depressive symptoms and impaired physical function after acute lung injury: a 2-year longitudinal study. Am J Respir Crit Care Med, 2012; 185(5):517–524.
9.
BienvenuOJ, GellarJ, AlthouseBM, ColantuoniE, SricharoenchaiT, Mendez-TellezPA, et al. Post-traumatic stress disorder symptoms after acute lung injury: a 2-year prospective longitudinal study. Psychol Med, 2013; 43(12):2657–2671.
10.
WareLB, MatthayMA. The acute respiratory distress syndrome. N Engl J Med, 2000; 342(18):1334–1349.
11.
SlutskyAS, TremblayLN. Multiple system organ failure: is mechanical ventilation a contributing factor?. Am J Respir Crit Care Med, 157(6 Pt 1):1721–1725, 1998.
12.
The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med, 2000; 342(18):1301–1308.
13.
PapazianL, ForelJM, GacouinA, Penot-RagonC, PerrinG, LoundouA, et al. ACURASYS Study Investigators. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med, 2010; 363(12):1107–1116.
14.
GuerinC, ReignierJ, RichardJC, BeuretP, GacouinA, BoulainT, et al. Prone positioning in severe acute respiratory distress syndrome. New Engl J Med, 2013; 368(23):2159–2168.
15.
PhuaJ, BadiaJR, AdhikariNK, FriedrichJO, FowlerRA, SinghJM, et al. Has mortality from acute respiratory distress syndrome decreased over time? A systematic review. Am J Respir Crit Care Med, 2009; 179(3):220–227.
16.
VillarJ, BlancoJ, KacmarekRM. Current incidence and outcome of the acute respiratory distress syndrome. Curr Opin Crit Care, 2016; 22(1):1–6.
17.
ShahNG, CowanMJ, PickeringE, SarehH, AfsharM, FoxD, et al. Nonpharmacologic approach to minimizing shivering during surface cooling: a proof of principle study. J Crit Care, 2012; 27(6):746e741–748.
18.
SlackDF, CorwinDS, ShahNG, ShanholtzCB, VercelesAC, NetzerG, et al. Pilot feasibility study of therapeutic hypothermia for moderate to severe acute respiratory distress syndrome. Crit Care Med, 2017; 45:1152–1157.
19.
LightRW, BengfortJL, GeorgeRB. The adult respiratory distress syndrome and pancuronium bromide. Anesth Analg, 1975; 54(2):219–223.
20.
Hansen-FlaschenJH, BrazinskyS, BasileC, LankenPN. Use of sedating drugs and neuromuscular blocking agents in patients requiring mechanical ventilation for respiratory failure: a national survey. JAMA, 1991; 266(20):2870–2875.
21.
BrowerRG, LankenPN, MacIntyreN, MatthayMA, MorrisA, AncukiewiczM, et al. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med, 2004; 351(4):327–336.
22.
MeadeMO, CookDJ, GuyattGH, SlutskyAS, ArabiYM, CooperDJ, et al. Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA, 2008; 299(6):637–645.
23.
MercatA, RichardJC, VielleB, JaberS, OsmanD, DiehlJL, et al. Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA, 2008; 299(6):646–655.
24.
TalmorD, SargeT, MalhotraA, O'DonnellCR, RitzR, LisbonA, et al. Mechanical ventilation guided by esophageal pressure in acute lung injury. N Engl J Med, 2008; 359(20):2095–2104.
25.
SesslerCN. Counterpoint: should paralytic agents be routinely used in severe ARDS? No. Chest, 2013; 144(5):1442–1445.
26.
HuangDT, AngusDC, MossM, ThompsonBT, FergusonND, GindeA, et al. Design and rationale of the reevaluation of systemic early neuromuscular blockade trial for acute respiratory distress syndrome. Ann Am Thorac Soc, 2017; 14(1):124–133.
27.
EysenbachG. Improving the quality of web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES). J Med Internet Res, 2004; 6(3):e34.
28.
LinIF, SchaefferNC. Using survey participants to estimate the impact of nonparticipation. Public Opin Q, 1995; 59:236–258.
29.
BellaniG, LaffeyJG, PhamT, FanE. LUNG SAFE Investigators and the ESICM Trials Group. The LUNG SAFE study: a presentation of the prevalence of ARDS according to the Berlin Definition!. Crit Care, 2016; 20:268.
30.
DuanEH, AdhikariNKJ, D'AragonF, CookDJ, MehtaS, AlhazzaniW, et al. Management of acute respiratory distress syndrome and refractory hypoxemia: a multicenter observational study. Ann Am Thorac Soc, 2017; 14(12):1818–1826.
31.
TorbicH, BauerSR, PersonettHA, DzierbaAL, StollingsJL, RyderLP, et al. Perceived safety and efficacy of neuromuscular blockers for acute respiratory distress syndrome among medical intensive care unit practitioners: a multicenter survey. J Crit Care, 2017; 38:278–283.
32.
AlhuraniRE, OecklerRA, FrancoPM, JenkinsSM, GajicO, PannuSR. Refractory hypoxemia and use of rescue strategies: a U.S. national survey of adult intensivists. Ann Am Thorac Soc, 2016; 13(7):1105–1114.
33.
BaruchY, HoltomB. Survey response rate levels and trends in organizational research. Hum Rel, 2008; 61(8):1139–1160.
34.
AitkenC, PowerR, DwyerR. A very low response rate in an on-line survey of medical practitioners. Aust N Z J Public Health, 2008; 32(3):288–289.
35.
CookDA, WittichCM, DanielsWL, WestCP, HarrisAM, BeebeTJ. Incentive and reminder strategies to improve response rate for internet-based physician surveys: a randomized experiment. J Med Internet Res, 2016; 18(9):e244.
36.
CunninghamCT, QuanH, HemmelgarnB, NoseworthyT, BeckCA, DixonE, et al. Exploring physician specialist response rates to web-based surveys. BMC Med Res Methodol, 2015; 15:32.
37.
National Heart, Lung, and Blood Institute PETAL Clinical Trials Network; MossM, HuangDT, BrowerRG, FergusonND, GindeAA, et al. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome. N Engl J Med, 2019; 380(21):1997–2008.
